Facebook Linkedin RSS Twitter Youtube
Home 2022

RNA interference

Atalanta Therapeutics’ Branched RNAi Hunts Down Neurodegenerative Diseases
GEN Edge

Atalanta Therapeutics’ Branched RNAi Hunts Down Neurodegenerative Diseases

Neighborhood Watch: Pangea Pursues Group Approach to Precision Oncology
Artificial Intelligence

Neighborhood Watch: Pangea Pursues Group Approach to Precision Oncology

Antabuse May Help Revive Sight in People with Blinding Disorders
Drug Discovery

Antabuse May Help Revive Sight in People with Blinding Disorders

Using RNAi to Produce More Effective Biotherapeutic Antibodies
Bioprocessing

Using RNAi to Produce More Effective Biotherapeutic Antibodies

Glioblastoma Therapy May Be Improved by Targeting Specific Enzyme
Cancer

Glioblastoma Therapy May Be Improved by Targeting Specific Enzyme

Molecular Events That Determine Cancer Cell Fate Uncovered
Cancer

Molecular Events That Determine Cancer Cell Fate Uncovered

Using RNAi and CRISPR Screening to Elucidate Biological Pathways
Genome Editing

Using RNAi and CRISPR Screening to Elucidate Biological Pathways

Redesigning the Global Food Supply
Genome Editing

Redesigning the Global Food Supply

Multimodal Screening—The Future of Drug Discovery and Development
Drug Discovery

Multimodal Screening—The Future of Drug Discovery and Development

RNA Drugs Can Escape Endosomal Confinement, Tumor Spheroids Confirm
Cancer

RNA Drugs Can Escape Endosomal Confinement, Tumor Spheroids Confirm

123...35Page 2 of 35
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.